• ImmunityBio reports positive data from Covid-19 vaccine trial pharmaceutical-technology
    November 11, 2020
    ImmunityBio has reported positive study results for its novel vaccine candidate, hAd5-COVID-19, which showed memory T-cell recall from patients previously infected with SARS-CoV-2, a virus that causes Covid-19.
PharmaSources Customer Service